Proliferative inhibition of human breast carcinoma cells by high concentration estradiol does not alter radiosensitivity-Reference-Cited by-同舟云学术

Proliferative inhibition of human breast carcinoma cells by high concentration estradiol does not alter radiosensitivity

Published:1991-08 Issue:3 Volume:18 Page:141-148
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Tr

Author:

Wazer David E.,Joyce Melita,Solares Guido,Schmidt-Ullrich Rupert

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF01990029.pdf

Reference30 articles.

1. Lippman M, Bolan G, Huff K: The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 36: 4595–4601, 1976

2. Bezwoda WR, Meyer K: Effect of a-interferon, 17β-estradiol, and tamoxifen on estrogen receptor concentration and cell cycle kinetics of MCF-7 cells. Cancer Res 50: 5387–5391, 1990

3. Reddel RR, Sutherland RL: Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell linein vitro. Cancer Res 47: 5323–5329, 1987

4. Adair FE, Mellors RC, Farrow JH, Woodward HQ, Escher GC, Urban JA: The use of oestrogen and androgens in advanced mammary cancer. J Am Med Assoc 140: 1193–1200, 1949

5. Binnie GG: Regression of tumours following treatment by stilboestrol and X-ray therapy. Br J Radiol 17: 42–45, 1944

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does the Time of Radiotherapy Affect Treatment Outcomes? A Review of the Literature;Clinical Oncology;2017-04

2. 10 −7 m 17β‐oestradiol enhances odonto/osteogenic potency of human dental pulp stem cells by activation of the NF‐κB pathway;Cell Proliferation;2013-10-24

3. Interactions between radiation and endocrine therapy in breast cancer.;Endocrine-related cancer;2003-09

4. Interactions between radiotherapy and endocrine therapy in breast cancer.;Endocrine-related cancer;2002-09

5. Cytotoxicity of 125 I-oestrogen decay in non-oestrogen receptor-expressing human breast cancer cells, MDA-231 and oestrogen receptor-expressing MCF-7 cells;International Journal of Radiation Biology;2001-01